In the carcinogenesis process, SNAI2 has been reported to take active part in metastasis, progression, differentiation, and drug sensitivity in multiple cancer types (Jin et al., 2022; Mazzu et al., 2022; Sorin et al., 2022). The gene discussed is SNAI2; the disease is cancer.